Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZPIV Accelerated Vaccination Schedule Study
NCT02937233Phase 1Completed
- Start
- Dec 2016
- Primary completion
- Jun 2018
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ZPIV in Zika virus infection (3 arms). Primary endpoints: Incidence, intensity, and relationship to vaccination of solicited local and systemic adverse events, Incidence, intensity, and relationship to vaccination of unsolicited local and systemic adverse events and 1 more. Started Dec 2016; status: completed.
02
Drugs
ZPIV
03
Conditions
Zika virus infection
Beyond the preview
Go deeper on NCT02937233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02937233.